no weight loss with tirzepatide obesity trial non-diabetic pros and cons for A 72-week compared the two leading GLP-1 medications in adults (no diabetes). The Tirzepatide outcompetes long-acting insulin in – GLP-1 drugs such as semaglutide

But even as semaglutide keeps evolving, researchers are studying newer medications that may push weight-loss results even further

The colonoscope frequently can reach the part of the small intestine that is adjacent to the right colon

Unexpected manufacturing problems, demand spikes, and tightened ingredient supply lines have all contributed to the shortages, which have subsequently caused treatment delays, medication switches and other hassles for doctors and patients

Your healthcare provider can determine which nutrients require monitoring based on your individual dietary intake and risk factors

Severe gastrointestinal problems: Rare cases of severe gastroparesis or intestinal obstruction

Contact our team to confirm availability in your location if outside of Tennessee